Chronic exposure to SCO-267, an allosteric GPR40 full agonist, is effective in improving glycemic control in rats

Ryokichi Koyama; Mitsugi Ookawara; Masanori Watanabe; Yusuke Moritoh

doi:10.1124/molpharm.120.000168

OtherArticle

Chronic exposure to SCO-267, an allosteric GPR40 full agonist, is effective in improving glycemic control in rats

Ryokichi Koyama, Mitsugi Ookawara, Masanori Watanabe and Yusuke Moritoh

Molecular Pharmacology February 5, 2021, MOLPHARM-AR-2020-000168; DOI: https://doi.org/10.1124/molpharm.120.000168

Ryokichi Koyama

1SCOHIA PHARMA, Inc., Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mitsugi Ookawara

1SCOHIA PHARMA, Inc., Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Masanori Watanabe

1SCOHIA PHARMA, Inc., Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yusuke Moritoh

1SCOHIA PHARMA, Inc., Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yusuke Moritoh
For correspondence: yusuke.moritoh@scohia.com

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Molecular Pharmacology

Vol. 99, Issue 3

1 Mar 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Chronic exposure to SCO-267, an allosteric GPR40 full agonist, is effective in improving glycemic control in rats

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherArticle